|
⚲
|
| Keyboard |
| Clal Biotechnology Industries Ltd
✚
|
|
|---|---|
| CIK # | 0001468950 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001468950] | |
| 4 | [0001468950] | |
| SC 13D | [0001468950] | |
| SC 13G | [0001468950] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neon Therapeutics Inc NTGN
Common Stock
|
2020-03-24 | Sell | 117,400 | $2.20 | 258,280 |
|
Neon Therapeutics Inc NTGN
Common Stock
|
2020-03-24 | Sell | 84,286 | $2.19 | 184,586 |
|
Neon Therapeutics Inc NTGN
Common Stock
|
2020-03-23 | Sell | 50,358 | $2.17 | 109,277 |
|
Neon Therapeutics Inc NTGN
Common Stock
|
2020-03-20 | Sell | 84,339 | $2.22 | 187,233 |
|
Neon Therapeutics Inc NTGN
Common Stock
|
2020-03-19 | Sell | 9,050 | $2.51 | 22,715 |
|
Neon Therapeutics Inc NTGN
Series B Preferred Stock · derivative
|
2018-06-29 | Conversion | 3,914,590 | ||
|
Neon Therapeutics Inc NTGN
Series A Preferred Stock · derivative
|
2018-06-29 | Conversion | 5,000,000 | ||
|
Neon Therapeutics Inc NTGN
Common Stock
|
2018-06-29 | Conversion | 999,998 | ||
|
Neon Therapeutics Inc NTGN
Common Stock
|
2018-06-29 | Conversion | 999,998 | ||
|
Neon Therapeutics Inc NTGN
Common Stock
|
2018-06-29 | Buy | 315,000 | $16.00 | 5,040,000 |
|
Neon Therapeutics Inc NTGN
Common Stock
|
2018-06-29 | Conversion | 782,917 | ||
|
Neon Therapeutics Inc NTGN
Series A Preferred Stock · derivative
|
2018-06-29 | Conversion | 5,000,000 | ||
|
Biocancell Therapeutics Inc BICL
Debenture · derivative
|
2012-07-31 | Conversion | |||
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-07-31 | Buy | 10,731,726 | $0.22 | 2,360,980 |
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-07-31 | Conversion | 4,147,171 | $0.22 | 912,378 |
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-01-24 | Other | 410,392 | $0.00 | |
|
Biocancell Therapeutics Inc BICL
Common stock
|
2012-01-24 | Buy | 8,199,400 | $0.26 | 2,131,844 |